Brief: Wanbury Ltd Receives 9 “No DMF Deficiency” Letters From USFDA For Metformin HCl
16/10/2026 09:43
BRIEF-Wanbury Ltd Receives 9 “No DMF Deficiency” Letters From USFDA For Metformin HCl Oct 16 (Reuters) - Wanbury Ltd WANB.NS:
RECEIVES 9 "NO DMF DEFICIENCY" LETTERS FROM USFDA FOR METFORMIN HCL
EXPANDS METFORMIN BUSINESS IN SAUDI ARABIA AND MEXICO
Further company coverage: WANB.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Wanbury
See all newsBrief: Wanbury Ltd Receives 9 “No DMF Deficiency” Letters From USFDA For Metformin HCl
Brief: Wanbury Files New Drug Master File In South Africa For Tramadol Hcl API
Brief: Wanbury June-Quarter PAT 32.4 Million Rupees
Brief: Wanbury Receives No DMF Deficiency Letter From USFDA For Multiple Andas
Brief: Wanbury Says Completion Of US FDA Inspection At Tanuku Facility